← Banking With Billy News

Why is $ZURA down today? -72.37% Lead drug tibulizumab missed its Phase 2 HS endpoint; the company is stopping that program. Analyst target: $18 (~340% above $4

BWB News TV • 2026-11-09 15:27 UTC • By Billy Odell Tucker-Robinson
Why is $ZURA down today? -72.37% Lead drug tibulizumab missed its Phase 2 HS endpoint; the company is stopping that program. Analyst target: $18 (~340% above $4
Why is $ZURA down today? -72.37% Lead drug tibulizumab missed its Phase 2 HS endpoint; the company is stopping that program. Analyst target: $18 (~340% above $4.09, 7-analyst mean). #Biotech #ClinicalTrial
Share this article
𝕏 X / Twitter Facebook LinkedIn WhatsApp
📚 More from Billy’s World
📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly